Torthaí cuardaigh - Thorbald van Hall
- 1 - 20 toradh as 55 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome de réir Cláudia C. Oliveira, Thorbald van Hall
Foilsithe / Cruthaithe 2015Revisão -
2
TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers de réir Koen A. Marijt, Elien M. Doorduijn, Thorbald van Hall
Foilsithe / Cruthaithe 2018Revisão -
3
The NKG2A–HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment de réir Linda Borst, Sjoerd H. van der Burg, Thorbald van Hall
Foilsithe / Cruthaithe 2020Revisão -
4
Future Challenges in Cancer Resistance to Immunotherapy de réir Marit J van Elsas, Thorbald van Hall, Sjoerd H. van der Burg
Foilsithe / Cruthaithe 2020Revisão -
5
The urgent need to recover MHC class I in cancers for effective immunotherapy de réir Federico Garrido, Natalia Aptsiauri, Elien M. Doorduijn, Ángel M. García-Lora, Thorbald van Hall
Foilsithe / Cruthaithe 2016Revisão -
6
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors de réir Jim Middelburg, Kristel Kemper, Patrick Engelberts, Aran F. Labrijn, Janine Schuurman, Thorbald van Hall
Foilsithe / Cruthaithe 2021Revisão -
7
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein de réir Jan Paul Medema, Joan de Jong, Thorbald van Hall, Cornelis J.M. Melief, Rienk Offringa
Foilsithe / Cruthaithe 1999Artigo -
8
Therapeutic cancer vaccines de réir Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg
Foilsithe / Cruthaithe 2015Revisão -
9
Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100 de réir Marianne J.B. van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, Rienk Offringa, Thorbald van Hall, Adnane Achour
Foilsithe / Cruthaithe 2009Artigo -
10
-
11
Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28 de réir Thorbald van Hall, Alice J.A.M. Sijts, Marcel Camps, Rienk Offringa, Cornelis J.M. Melief, Peter‐M. Kloetzel, Ferry Ossendorp
Foilsithe / Cruthaithe 2000Artigo -
12
Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling de réir Koen A. Marijt, Marjolein Sluijter, Laura Blijleven, Sofie H. Tolmeijer, Ferenc A. Scheeren, Sjoerd H. van der Burg, Thorbald van Hall
Foilsithe / Cruthaithe 2019Artigo -
13
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors de réir Elien M. Doorduijn, Marjolein Sluijter, Bianca Querido, Cláudia C. Oliveira, Adnane Achour, Ferry Ossendorp, Sjoerd H. van der Burg, Thorbald van Hall
Foilsithe / Cruthaithe 2016Artigo -
14
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma de réir Mehrdad Talebian Yazdi, Sander van Riet, Annemarie van Schadewijk, Marta Fiocco, Thorbald van Hall, Christian Taube, Pieter S. Hiemstra, Sjoerd H. van der Burg
Foilsithe / Cruthaithe 2015Artigo -
15
CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy de réir Elien M. Doorduijn, Marjolein Sluijter, Daniela Salvatori, Serenella Silvestri, Saskia Maas, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg, Thorbald van Hall
Foilsithe / Cruthaithe 2017Artigo -
16
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy de réir Marieke F. Fransen, Mark J.A. Schoonderwoerd, Philipp Knopf, Marcel Camps, Lukas J.A.C. Hawinkels, Manfred Kneilling, Thorbald van Hall, Ferry Ossendorp
Foilsithe / Cruthaithe 2018Artigo -
17
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy de réir Jim Middelburg, Gaby Schaap, Marjolein Sluijter, Katy A. Lloyd, Vitalijs Ovcinnikovs, Janine Schuurman, Sjoerd H. van der Burg, Kristel Kemper, Thorbald van Hall
Foilsithe / Cruthaithe 2025Artigo -
18
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory de réir Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, Sandra Verploegen, Aran F. Labrijn, Danita H. Schuurhuis, Mischa Houtkamp, J. Sjef Verbeek, Janine Schuurman, Thorbald van Hall
Foilsithe / Cruthaithe 2018Artigo -
19
Monalizumab: inhibiting the novel immune checkpoint NKG2A de réir Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Émilie Narni-Mancinelli, Sjoerd H. van der Burg, Éric Vivier
Foilsithe / Cruthaithe 2019Revisão -
20
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy de réir Marit J van Elsas, Camilla Labrie, Anders Etzerodt, Pornpimol Charoentong, Jordi J C van Stigt Thans, Thorbald van Hall, Sjoerd H. van der Burg
Foilsithe / Cruthaithe 2023Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Immunology
Immune system
Cancer research
Biology
Medicine
CD8
Biochemistry
Antigen
Immunotherapy
In vitro
Cancer
T cell
Cytotoxic T cell
Internal medicine
Genetics
Cell biology
Major histocompatibility complex
MHC class I
Tumor microenvironment
Receptor
Antibody
Cancer immunotherapy
Gene
Antigen presentation
Chemistry
Antigen processing
Blockade
Immune checkpoint
Macrophage
Melanoma